Ziphius Vaccines

[Not Yet Scheduled]
Ziphius Vaccines NV is a self-amplifying RNA company developing transformative vaccines for infectious diseases and protein enhancement therapy, in order to create a new generation of medicines. The Company has a portfolio of next generation vaccine candidates targeting a wide range of infectious diseases.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Belgium
Year Founded:
2019
Main Therapeutic Focus:
Lead Product in Development:
ZIP-1642
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
5
Speaker
photo
Business Development & Licencing Officer
Ziphius Vaccines